HRSA Announces Action To Lower Out-Of-Pocket Costs For Life-Saving Medications
June 24 (Reuters) - HRSA:
HRSA ANNOUNCES ACTION TO LOWER OUT-OF-POCKET COSTS FOR LIFE-SAVING MEDICATIONS AT HEALTH CENTERS NATIONWIDE
340B DRUG PRICING PROGRAM ALLOWS ELIGIBLE HEALTH CARE ORGANIZATIONS TO PURCHASE OUTPATIENT DRUGS AT SIGNIFICANTLY REDUCED PRICES
HRSA REQUIRES HRSA-FUNDED HEALTH CENTERS TO PROVIDE INSULIN & INJECTABLE EPINEPHRINE TO LOW-INCOME PATIENTS AT OR BELOW PRICE PAID BY CENTER
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Precious Metals May Outlook: After U.S.-Iran Conflict Concerns Eased, Will Funds Flow Back to Gold and Silver?

Intel vs. TSM: Which Semiconductor Stock Looks Like the Better Investment?

ORCL Stock: Why Oracle May Be the Beaten-Down Tech Giant Ready for a Comeback

What Is Intel, and Is Its Stock Still a Worthwhile Investment?

POET Technologies Stock Could Still Surge in 2026, but the Bar for a Breakout Is Higher Now

Tradingkey






